Summary This article explores the latest advancements in diabetes treatment, focusing on new drug options like SGLT2 inhibitors, GLP-1 receptor agonists, and tirzepatide. These medications offer improved blood sugar control, weight loss benefits, and even […]
Summary This article explores the latest advancements in diabetes management, focusing on new medication options like GLP-1 receptor agonists, SGLT-2 inhibitors, and Tirzepatide. It also discusses the role of technology, including continuous glucose monitors (CGMs) […]
Summary SGLT2 inhibitors are transforming diabetes care by offering a novel approach to blood sugar control and demonstrating remarkable benefits for kidney and heart health. These medications work independently of insulin by preventing the kidneys […]
Summary Continuous glucose monitors (CGMs) are revolutionizing diabetes care, as new research demonstrates their ability to predict diabetes-related complications like nerve, eye, and kidney damage. This breakthrough allows for earlier intervention and personalized treatment strategies, […]
Summary This article explores the shift away from a standardized approach to Type 1 diabetes management towards personalized treatment plans. Advancements such as continuous glucose monitors (CGMs), automated insulin delivery systems, and a deeper understanding […]
Summary A groundbreaking study reveals a novel treatment strategy combining the ReCET procedure with semaglutide, eliminating insulin therapy for 86% of type 2 diabetes patients. This innovative approach offers a potential solution to the challenges […]
Summary This article delves into the promising advancements in diabetes management, focusing on innovative treatment strategies and the evolving understanding of diabetes pathogenesis. From breakthroughs in beta cell regeneration and immunotherapy to novel drug therapies, […]
Summary Teplizumab, a novel immunotherapy drug, has shown promising results in delaying the onset of type 1 diabetes in clinical trials led by Yale researchers. The drug works by modulating the immune system’s attack on […]
Summary This article explores the heightened cardiovascular risks associated with type 2 diabetes and emphasizes the crucial role of comprehensive management strategies. Beyond glucose control, the discussion encompasses blood pressure and lipid management, lifestyle modifications, […]
Summary Zydus Lifesciences has partnered with CVS Caremark, adding its diabetes medications Zituvio, Zituvimet, and Zituvimet XR to the CVS Caremark template formulary. This collaboration aims to improve access to essential diabetes medications and marks […]
© 2026 Newsguru LTD. All rights reserved.